Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Clin Cancer Res. 2013 Dec 5;20(5):1104–1113. doi: 10.1158/1078-0432.CCR-13-1573

Figure 1.

Figure 1

Metabolism of sulindac. Prodrug sulindac undergoes reversible reduction into the active sulfide form through the action of liver enzymes and colonic bacteria. Sulindac sulfide is a non-selective COX inhibitor and is responsible for the anti-inflammatory properties of sulindac. The sulfone metabolite is generated by irreversible oxidation of the sulfoxide in the liver, and does not have anti-inflammatory activity. Figure adapted from Gurpinar et al., Frontiers in Oncology, 2013 (106).